← All organizations

Clinuvel Pharmaceuticals Limited

For profitContributed to NMEWebsite ↗

Also known as: City Clinical Oncology Hospital No 1 | Clinuvel Europe Limited | Clinuvel, Inc. | Clinuvel Pharmaceuticals Limited | CLINUVEL PHARMACEUTICALS LTD | Clinuvel (UK) Ltd. | CLIVUNEL INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Mar 1, 2025

Timeline

1980s

Jan 1, 1987
Clinuvel Pharmaceuticals Limited— Founded

2010s

Oct 8, 2019
afamelanotide— Marketing Organization
Oct 17, 2019
afamelanotide— NDA Organization

Drugs by trial phase (11 distinct, 26 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

afamelanotide

Recent trials (32)

NCT06967155CollaboratorPhase 2Mar 1, 2025
NCT06978400CollaboratorPhase 2Mar 1, 2025
NCT06388642Lead sponsorPhase 1/Phase 2Mar 7, 2024
NCT06226857Sponsor investigatorPhase 3Jan 17, 2024
NCT06226857Lead sponsorPhase 3Jan 17, 2024
NCT06109649Lead sponsorPhase 3Oct 11, 2023
NCT05854784Lead sponsorPhase 2Mar 28, 2023
NCT05210582Lead sponsorPhase 2Oct 11, 2022
NCT05551767Lead sponsorPhase 2Aug 30, 2022
NCT05551767Overall official - principal investigatorPhase 2Aug 30, 2022
NCT05370235Lead sponsorPhase 2Mar 28, 2022
NCT05368857Lead sponsorPhase 1Jan 19, 2022
NCT05159752Lead sponsorPhase 2Oct 19, 2021
NCT04962503Lead sponsorPhase 2Jun 3, 2021
NCT04525157Study directorPhase 2Jun 6, 2014

Details

Founded: Melbourne, AU Jan 1, 1987
First NDA: Oct 17, 2019
Last known activity: Mar 1, 2025

Designations held

Orphan drug
Fast track
Priority review